University of Nevada, Las Vegas   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Paradise NV United States (1957)

Organization Overview

First Clinical Trial
2016
NCT04292171
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

University of Nevada at Las Vegas | University of Nevada, Las Vegas | UNLV, Las Vegas

Active Ingredients

Drugs in Phase 4 Trials (1)

albuterol (proventil) (2 trials)

Drugs in Phase 1 Trials (2)

gabapentin (neurontin) (1 trial)

strawberry (2 trials)

Drugs in Other Trials (7)

artemether (1 trial)

blueberry (1 trial)

chlorfenapyr (1 trial)

cypermethrin (1 trial)

egg (1 trial)

lumefantrine (Coartem) (1 trial)

primaquine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Asthma, Exercise-Induced (Phase 4)

Bronchial Spasm (Phase 4)

Dyspnea (Phase 4)

Obesity (Phase 4)

Pediatric Obesity (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 10